Who owns RELMADA THERAPEUTICS, INC.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of RLMD from SEC Form 13F filings across 134 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 134 institutions disclosed 104.4M shares of RELMADA THERAPEUTICS, INC. worth $394.3M — about 92.8% of shares outstanding; the largest disclosed holder is Janus Henderson Group Ltd.. Source: SEC Form 13F filings, parsed by EvidInvest.
134
13F holders
$394.3M
value, 2026 filers
92.8%
of shares outstanding (104.4M sh)
23
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of RLMD's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Janus Henderson Group Ltd.NEW | 11.2M | $42.0M | 0.0% | 9.9% | new |
| 2 | BlackRock, Inc. | 7.6M | $28.6M | 0.0% | 6.7% | +2.0% |
| 3 | Venrock Adviser, LLC | 7.4M | $28.1M | 1.4% | 6.6% | +8.8% |
| 4 | Spruce Street Capital LP | 6.9M | $26.1M | 4.1% | 6.1% | +8.1% |
| 5 | Jones Hill Capital LP | 5.2M | $19.7M | 3.4% | 4.7% | +43.3% |
| 6 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 4.8M | $18.0M | 0.0% | 4.2% | 0.0% |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | 4.4M | $16.4M | 0.0% | 3.9% | -2.3% |
| 8 | AMERIPRISE FINANCIAL INC | 3.7M | $14.0M | 0.0% | 3.3% | +92.1% |
| 9 | Sio Capital Management, LLC | 3.6M | $13.7M | 2.6% | 3.2% | +261.7% |
| 10 | Squadron Capital Management LLC | 3.5M | $13.2M | 3.3% | 3.1% | -52.4% |
| 11 | MILLENNIUM MANAGEMENT LLC | 3.3M | $12.6M | 0.0% | 3% | +41.7% |
| 12 | STATE STREET CORP | 3.3M | $12.5M | 0.0% | 2.9% | +31.5% |
| 13 | GEODE CAPITAL MANAGEMENT, LLC | 2.4M | $8.9M | 0.0% | 2.1% | -5.3% |
| 14 | Commodore Capital LP | 2.4M | $8.9M | 0.7% | 2.1% | +64.9% |
| 15 | FRANKLIN TEMPLETON INCNEW | 2.2M | $9.4M | 0.0% | 2% | new |
| 16 | Driehaus Capital Management LLC | 2.1M | $8.0M | 0.1% | 1.9% | 0.0% |
| 17 | Qube Research & Technologies Ltd | 1.9M | $7.2M | 0.0% | 1.7% | +176.4% |
| 18 | EVENTIDE ASSET MANAGEMENT, LLC | 1.9M | $7.0M | 0.1% | 1.7% | 0.0% |
| 19 | ORBIMED ADVISORS LLC | 1.7M | $6.3M | 0.1% | 1.5% | -54.0% |
| 20 | Balyasny Asset Management L.P. | 1.5M | $5.7M | 0.0% | 1.3% | -1.1% |
| 21 | Ikarian Capital, LLC | 1.4M | $5.5M | 0.5% | 1.3% | -32.6% |
| 22 | Polar Capital Holdings Plc | 1.3M | $5.0M | 0.0% | 1.2% | -0.3% |
| 23 | VANGUARD PORTFOLIO MANAGEMENT LLC | 1.2M | $4.5M | 0.0% | 1.1% | +31.4% |
| 24 | Walleye Capital LLC | 1.0M | $3.8M | 0.0% | 0.9% | +64.8% |
| 25 | Opaleye Management Inc. | 1.0M | $3.8M | 0.4% | 0.9% | +7.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.